5-[[6-(cyclohexen-1-yl)-3-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyrazin-8-yl]amino]-N-ethyl-3-methylthiophene-2-carboxamide;5-[[6-(cyclohexen-1-yl)-3-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyrazin-8-yl]amino]-3-methyl-N-(1-methylsulfonylpiperidin-4-yl)thiophene-2-carboxamide;5-[[6-(cyclohexen-1-yl)-3-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyrazin-8-yl]amino]-3-methylthiophene-2-carboxamide;5-[[6-(cyclohexen-1-yl)-3-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyrazin-8-yl]amino]-N,N,3-trimethylthiophene-2-carboxamide
C98H111N29O6S5 — CID 123985435
Data last refreshed: (MolForge compound catalog, from PubChem)
About 5-[[6-(cyclohexen-1-yl)-3-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyrazin-8-yl]amino]-N-ethyl-3-methylthiophene-2-carboxamide;5-[[6-(cyclohexen-1-yl)-3-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyrazin-8-yl]amino]-3-methyl-N-(1-methylsulfonylpiperidin-4-yl)thiophene-2-carboxamide;5-[[6-(cyclohexen-1-yl)-3-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyrazin-8-yl]amino]-3-methylthiophene-2-carboxamide;5-[[6-(cyclohexen-1-yl)-3-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyrazin-8-yl]amino]-N,N,3-trimethylthiophene-2-carboxamide
5-[[6-(cyclohexen-1-yl)-3-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyrazin-8-yl]amino]-N-ethyl-3-methylthiophene-2-carboxamide;5-[[6-(cyclohexen-1-yl)-3-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyrazin-8-yl]amino]-3-methyl-N-(1-methylsulfonylpiperidin-4-yl)thiophene-2-carboxamide;5-[[6-(cyclohexen-1-yl)-3-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyrazin-8-yl]amino]-3-methylthiophene-2-carboxamide;5-[[6-(cyclohexen-1-yl)-3-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyrazin-8-yl]amino]-N,N,3-trimethylthiophene-2-carboxamide (PubChem CID 123985435) has the molecular formula C98H111N29O6S5 and a molecular weight of 1951.50 g/mol. Its IUPAC name is 5-[[6-(cyclohexen-1-yl)-3-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyrazin-8-yl]amino]-N-ethyl-3-methylthiophene-2-carboxamide;5-[[6-(cyclohexen-1-yl)-3-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyrazin-8-yl]amino]-3-methyl-N-(1-methylsulfonylpiperidin-4-yl)thiophene-2-carboxamide;5-[[6-(cyclohexen-1-yl)-3-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyrazin-8-yl]amino]-3-methylthiophene-2-carboxamide;5-[[6-(cyclohexen-1-yl)-3-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyrazin-8-yl]amino]-N,N,3-trimethylthiophene-2-carboxamide.
Molecular Properties
| Compound Name | 5-[[6-(cyclohexen-1-yl)-3-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyrazin-8-yl]amino]-N-ethyl-3-methylthiophene-2-carboxamide;5-[[6-(cyclohexen-1-yl)-3-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyrazin-8-yl]amino]-3-methyl-N-(1-methylsulfonylpiperidin-4-yl)thiophene-2-carboxamide;5-[[6-(cyclohexen-1-yl)-3-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyrazin-8-yl]amino]-3-methylthiophene-2-carboxamide;5-[[6-(cyclohexen-1-yl)-3-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyrazin-8-yl]amino]-N,N,3-trimethylthiophene-2-carboxamide |
|---|---|
| PubChem CID | 123985435 |
| Molecular Formula | C98H111N29O6S5 |
| Molecular Weight | 1951.50 g/mol |
| Exact Mass | 1949.79 |
| IUPAC Name | 5-[[6-(cyclohexen-1-yl)-3-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyrazin-8-yl]amino]-N-ethyl-3-methylthiophene-2-carboxamide;5-[[6-(cyclohexen-1-yl)-3-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyrazin-8-yl]amino]-3-methyl-N-(1-methylsulfonylpiperidin-4-yl)thiophene-2-carboxamide;5-[[6-(cyclohexen-1-yl)-3-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyrazin-8-yl]amino]-3-methylthiophene-2-carboxamide;5-[[6-(cyclohexen-1-yl)-3-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyrazin-8-yl]amino]-N,N,3-trimethylthiophene-2-carboxamide |
| SMILES | CCNC(=O)c1sc(Nc2nc(C3=CCCCC3)cn3c(-c4cnn(C)c4)cnc23)cc1C.Cc1cc(Nc2nc(C3=CCCCC3)cn3c(-c4cnn(C)c4)cnc23)sc1C(=O)N(C)C.Cc1cc(Nc2nc(C3=CCCCC3)cn3c(-c4cnn(C)c4)cnc23)sc1C(=O)NC1CCN(S(C)(=O)=O)CC1.Cc1cc(Nc2nc(C3=CCCCC3)cn3c(-c4cnn(C)c4)cnc23)sc1C(N)=O |
| InChI | InChI=1S/C28H34N8O3S2.2C24H27N7OS.C22H23N7OS/c1-18-13-24(40-25(18)28(37)31-21-9-11-35(12-10-21)41(3,38)39)33-26-27-29-15-23(20-14-30-34(2)16-20)36(27)17-22(32-26)19-7-5-4-6-8-19;1-15-10-20(33-21(15)24(32)29(2)3)28-22-23-25-12-19(17-11-26-30(4)13-17)31(23)14-18(27-22)16-8-6-5-7-9-16;1-4-25-24(32)21-15(2)10-20(33-21)29-22-23-26-12-19(17-11-27-30(3)13-17)31(23)14-18(28-22)16-8-6-5-7-9-16;1-13-8-18(31-19(13)20(23)30)27-21-22-24-10-17(15-9-25-28(2)11-15)29(22)12-16(26-21)14-6-4-3-5-7-14/h7,13-17,21H,4-6,8-12H2,1-3H3,(H,31,37)(H,32,33);8,10-14H,5-7,9H2,1-4H3,(H,27,28);8,10-14H,4-7,9H2,1-3H3,(H,25,32)(H,28,29);6,8-12H,3-5,7H2,1-2H3,(H2,23,30)(H,26,27) |
| InChIKey | WWRYOAGTGFRSGG-UHFFFAOYSA-N |
| XLogP | 18.51 |
| TPSA | 399.14 Ų |
| H-Bond Donors | 7 |
| H-Bond Acceptors | 34 |
| Rotatable Bonds | 23 |
| Heavy Atoms | 138 |
| Complexity | — |
Lipinski Rule of Five
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 1951.50 |
| LogP ≤ 5 | 18.51 |
| H-Bond Donors ≤ 5 | 7 |
| H-Bond Acceptors ≤ 10 | 34 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 123985435 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.